Range
21.73 - 22.48
Vol / Avg.
2.9M/1.6M
Div / Yield
-
52 Wk
18.18 - 27.35
Mkt Cap
7B
Payout Ratio
-
Open
22.06
P/E
109.33
EPS
0.01
Shares
313.4M
Outstanding
313.4M
Total Float
277.4M
Benzinga - 2 days ago
Benzinga - 5 days ago
Benzinga - 6 days ago
Benzinga - Jun 7, 2021, 8:03AM
Benzinga - Jun 4, 2021, 9:01AM
Benzinga - May 24, 2021, 4:05PM
Benzinga - May 7, 2021, 8:51AM
Benzinga - May 6, 2021, 4:53PM
Benzinga - May 6, 2021, 4:50PM
Benzinga - May 4, 2021, 8:03AM
Benzinga - Apr 19, 2021, 10:33AM
Benzinga - Apr 5, 2021, 8:02AM
Benzinga - Mar 31, 2021, 7:10AM
Benzinga - Mar 30, 2021, 8:21AM
Benzinga - Mar 12, 2021, 8:59AM
Benzinga - Mar 8, 2021, 8:19AM
Benzinga - Feb 25, 2021, 11:11AM
Benzinga - Feb 25, 2021, 8:25AM
Benzinga - Feb 16, 2021, 9:19AM
Benzinga - Feb 11, 2021, 8:04AM
load more
Sector: Health Care.Industry: Biotechnology
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule cabozantinib is indicated for the treatment of patients with metastatic medullary thyroid cancer (as Cometriq) and advanced renal cell carcinoma, or kidney cancer, and hepatocellular carcinoma, or liver cancer (as Cabometyx). Exelixis and partner Roche have also brought Cotellic to market for the treatment of melanoma.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-05
REV
Q1 2021Est.ActualSurprise
EPS0.0300.090 0.0600
REV265.940M270.230M4.290M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
EXELExelixis1.27%7B

Exelixis Frequently Asked Questions

Q

How do I buy Exelixis (EXEL) stock?

A

You can purchase shares of Exelixis (NASDAQ: EXEL) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Exelixis's (EXEL) competitors?

A

Other companies in Exelixis’s space includes: Twist Bioscience (NASDAQ:TWST), Legend Biotech (NASDAQ:LEGN), Ultragenyx Pharmaceutical (NASDAQ:RARE), Sarepta Therapeutics (NASDAQ:SRPT) and Neurocrine Biosciences (NASDAQ:NBIX).

Q

What is the target price for Exelixis (EXEL) stock?

A

The latest price target for Exelixis (NASDAQ: EXEL) was reported by HC Wainwright & Co. on June 15, 2021. The analyst firm set a price target for 47.00 expecting EXEL to rise to within 12 months (a possible 109.73% upside). 12 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Exelixis (EXEL)?

A

The stock price for Exelixis (NASDAQ: EXEL) is $22.41 last updated Fri Jun 18 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

Does Exelixis (EXEL) pay a dividend?

A

There are no upcoming dividends for Exelixis.

Q

When is Exelixis (NASDAQ:EXEL) reporting earnings?

A
Exelixis’s Q2 earnings are confirmed for after-market on August 5, 2021.
Q

Is Exelixis (EXEL) going to split?

A

There is no upcoming split for Exelixis.

Q

What sector and industry does Exelixis (EXEL) operate in?

A

Exelixis is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.